Standout Papers
- Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies (2021)
- Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies (2022)
- GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential (2021)
Immediate Impact
52 standout
Citing Papers
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
2025 Standout
Works of Iqra Ilyas being referenced
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
2021 Standout
Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Iqra Ilyas | 274 | 181 | 236 | 456 | 255 | 16 | 1.3k | |
| Lijun Sun | 92 | 158 | 92 | 551 | 188 | 23 | 1.7k | |
| Antonio Damato | 216 | 137 | 267 | 364 | 126 | 39 | 1.3k | |
| Carine M. Boustany‐Kari | 104 | 173 | 250 | 391 | 256 | 20 | 1.2k | |
| Christopher T. Chan | 520 | 156 | 338 | 519 | 188 | 16 | 1.5k | |
| Jayakumar Thangavel | 231 | 109 | 236 | 497 | 84 | 8 | 1.4k | |
| Rossella D’Oria | 150 | 183 | 287 | 456 | 205 | 17 | 1.5k | |
| Shutaro Ishimura | 67 | 323 | 278 | 668 | 172 | 19 | 1.2k | |
| Tlili Barhoumi | 374 | 113 | 441 | 279 | 368 | 47 | 1.5k | |
| Nathan P. Rudemiller | 326 | 100 | 372 | 360 | 304 | 32 | 1.5k | |
| Zhongren Ding | 227 | 122 | 447 | 376 | 87 | 40 | 1.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...